As of 2026-09-16, the Relative Valuation of Eupraxia Pharmaceuticals Inc (EPRX.TO) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 11.08 CAD, the upside of Eupraxia Pharmaceuticals Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2026-09-11 | -17.09 |
| 2026-09-10 | -16.20 |
| 2026-09-09 | -16.22 |
| 2026-09-08 | -16.65 |
| 2026-09-04 | -17.02 |
| 2026-09-03 | -15.15 |
| 2026-09-02 | -15.06 |
| 2026-09-01 | -12.85 |
| 2026-08-31 | -13.12 |
| 2026-08-28 | -13.57 |
| 2026-08-27 | -14.87 |
| 2026-08-26 | -15.03 |
| 2026-08-25 | -14.91 |
| 2026-08-24 | -14.70 |
| 2026-08-21 | -13.60 |
| 2026-08-20 | -13.63 |
| 2026-08-19 | -14.21 |
| 2026-08-18 | -13.89 |
| 2026-08-17 | -13.89 |
| 2026-08-14 | -13.61 |
| 2026-08-13 | -13.63 |
| 2026-08-12 | -13.29 |
| 2026-08-11 | -13.67 |
| 2026-08-10 | -13.70 |
| 2026-08-07 | -13.83 |
| 2026-08-06 | -13.64 |
| 2026-08-05 | -13.26 |
| 2026-08-04 | -13.34 |
| 2026-07-31 | -13.13 |
| 2026-07-30 | -13.31 |
| 2026-07-29 | -12.25 |
| 2026-07-28 | -12.50 |
| 2026-07-27 | -12.78 |
| 2026-07-24 | -12.02 |
| 2026-07-23 | -12.96 |
| 2026-07-22 | -13.31 |
| 2026-07-21 | -13.15 |
| 2026-07-20 | -12.91 |
| 2026-07-17 | -13.55 |
| 2026-07-16 | -12.69 |
| 2026-07-15 | -13.41 |
| 2026-07-14 | -13.03 |
| 2026-07-13 | -13.29 |
| 2026-07-10 | -13.83 |
| 2026-07-09 | -14.33 |
| 2026-07-08 | -14.33 |
| 2026-07-07 | -13.86 |
| 2026-07-06 | -13.57 |
| 2026-07-03 | -13.93 |
| 2026-07-02 | -13.82 |